Back to today’s briefing

Story perspectives

Hope for Alzheimer's: New Antibody Trial Begins

2/7/2025

47 4

Summary

Story summary

A groundbreaking clinical trial at Washington University School of Medicine is testing remternetug, an innovative antibody designed to prevent Alzheimer’s disease in those genetically at risk. With 240 participants, this two-year study aims to halt the buildup of amyloid beta, a crucial contributor to the disease's progression, offering hope for a brighter future.

1 of 1

Story summary

A groundbreaking clinical trial at Washington University School of Medicine is testing remternetug, an innovative antibody designed to prevent Alzheimer’s disease in those genetically at risk. With 240 participants, this two-year study aims to halt the buildup of amyloid beta, a crucial contributor to the disease's progression, offering hope for a brighter future.